Category: Healthcare

The global canine arthritis treatment market is projected to grow significantly, reaching a valuation of USD 2.51 billion in 2024 and surging to USD 3.78 billion by 2034

The global market for canine atopic dermatitis treatment is projected to grow from USD 1,183.6 million in 2024 to USD 1,621.5 million by 2034, achieving a compound annual growth rate (CAGR) of 4.2% over the forecast period.

The global canine cancer screening market is projected to experience robust growth, with its valuation increasing from USD 1.40 billion in 2024 to USD 2.09 billion by 2034.

The global cannabis use disorder (CUD) treatment market is projected to grow significantly, with a market value expected to increase from USD 1.66 billion in 2024 to USD 2.67 billion by 2034, showcasing a robust CAGR of 5.9% over the forecast period.

The global capnography equipment market is anticipated to experience significant growth, expanding from USD 335 million in 2024 to USD 537 million by 2034, at an updated CAGR of 5.4%.

The global market for canine dilated cardiomyopathy (DCM) drugs is poised to grow from USD 3,644.6 million in 2024 to USD 5,823.9 million by 2034, reflecting a CAGR of 5.8% over the forecast period.

The global canine flu therapeutics market is poised for substantial growth, with its valuation projected to rise from USD 2.05 billion in 2024 to USD 3.07 billion by 2034, reflecting a steady CAGR of 5.1%.

The global caprolactam market is projected to grow from USD 16,447.9 million in 2024 to USD 25,113.8 million by 2034, reflecting a CAGR of 4.9% during the forecast period.

The global capsule endoscope and workstations market is set to grow significantly, rising from USD 180.9 million in 2024 to USD 842.0 million by 2034.

The global cognitive neuroscience market is projected to grow significantly, with an estimated valuation of USD 38.82 billion in 2024, reaching USD 67.58 billion by 2034.